Cargando…
The road for survival improvement of cystic fibrosis patients in Arab countries
Cystic fibrosis (CF) is a lethal, monogenic disorder that affects multiple organ systems of the body. The incidence has been described before in the Middle East to be 1 in 2000 to 1 in 5800 live births, and the median survival was estimated to be from 10 to 20 years of age. The present article attem...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372404/ https://www.ncbi.nlm.nih.gov/pubmed/30805437 http://dx.doi.org/10.1016/j.ijpam.2015.05.006 |
_version_ | 1783394728874606592 |
---|---|
author | Banjar, Hanaa Angyalosi, Gerhild |
author_facet | Banjar, Hanaa Angyalosi, Gerhild |
author_sort | Banjar, Hanaa |
collection | PubMed |
description | Cystic fibrosis (CF) is a lethal, monogenic disorder that affects multiple organ systems of the body. The incidence has been described before in the Middle East to be 1 in 2000 to 1 in 5800 live births, and the median survival was estimated to be from 10 to 20 years of age. The present article attempts to revisit various facets of this disease and specifically highlights the most important lacunae that exist in treating CF. In addition, it also tries to emphasize the steps in improving the median survival of patients with CF, in these countries. |
format | Online Article Text |
id | pubmed-6372404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | King Faisal Specialist Hospital and Research Centre |
record_format | MEDLINE/PubMed |
spelling | pubmed-63724042019-02-25 The road for survival improvement of cystic fibrosis patients in Arab countries Banjar, Hanaa Angyalosi, Gerhild Int J Pediatr Adolesc Med Invited Review Cystic fibrosis (CF) is a lethal, monogenic disorder that affects multiple organ systems of the body. The incidence has been described before in the Middle East to be 1 in 2000 to 1 in 5800 live births, and the median survival was estimated to be from 10 to 20 years of age. The present article attempts to revisit various facets of this disease and specifically highlights the most important lacunae that exist in treating CF. In addition, it also tries to emphasize the steps in improving the median survival of patients with CF, in these countries. King Faisal Specialist Hospital and Research Centre 2015-06 2015-06-19 /pmc/articles/PMC6372404/ /pubmed/30805437 http://dx.doi.org/10.1016/j.ijpam.2015.05.006 Text en Copyright © 2015, King Faisal Specialist Hospital & Research Centre (General Organization),. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Invited Review Banjar, Hanaa Angyalosi, Gerhild The road for survival improvement of cystic fibrosis patients in Arab countries |
title | The road for survival improvement of cystic fibrosis patients in Arab countries |
title_full | The road for survival improvement of cystic fibrosis patients in Arab countries |
title_fullStr | The road for survival improvement of cystic fibrosis patients in Arab countries |
title_full_unstemmed | The road for survival improvement of cystic fibrosis patients in Arab countries |
title_short | The road for survival improvement of cystic fibrosis patients in Arab countries |
title_sort | road for survival improvement of cystic fibrosis patients in arab countries |
topic | Invited Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372404/ https://www.ncbi.nlm.nih.gov/pubmed/30805437 http://dx.doi.org/10.1016/j.ijpam.2015.05.006 |
work_keys_str_mv | AT banjarhanaa theroadforsurvivalimprovementofcysticfibrosispatientsinarabcountries AT angyalosigerhild theroadforsurvivalimprovementofcysticfibrosispatientsinarabcountries AT banjarhanaa roadforsurvivalimprovementofcysticfibrosispatientsinarabcountries AT angyalosigerhild roadforsurvivalimprovementofcysticfibrosispatientsinarabcountries |